Correlation Between Phio Pharmaceuticals and Neurosense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Neurosense Therapeutics, you can compare the effects of market volatilities on Phio Pharmaceuticals and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Neurosense Therapeutics.

Diversification Opportunities for Phio Pharmaceuticals and Neurosense Therapeutics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Phio and Neurosense is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and Neurosense Therapeutics

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to generate 1.71 times more return on investment than Neurosense Therapeutics. However, Phio Pharmaceuticals is 1.71 times more volatile than Neurosense Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Neurosense Therapeutics is currently generating about -0.53 per unit of risk. If you would invest  301.00  in Phio Pharmaceuticals Corp on August 27, 2024 and sell it today you would lose (54.00) from holding Phio Pharmaceuticals Corp or give up 17.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  Neurosense Therapeutics

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Neurosense Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Neurosense Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Phio Pharmaceuticals and Neurosense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and Neurosense Therapeutics

The main advantage of trading using opposite Phio Pharmaceuticals and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.
The idea behind Phio Pharmaceuticals Corp and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum